Spondyloarthropathies

Top Story

The Balancing Act of Managing Spondyloarthropathies

The Balancing Act of Managing Spondyloarthropathies
Healio Rheumatology, September 2017

Clinicians treating patients with spondyloarthropathies are required to walk many tightropes. One is the prevention of infections while treating patients with immunosuppressive drugs. Another is determining where clinical manifestations of spondyloarthritis end and the adverse event profile of the medication begins. Another is deciding when mainstay therapies, like tumor necrosis factor inhibitors, are working and when to move on to an agent with a novel or different target. The backdrop of all of this is little is known about the genetic factors that predispose patients to these diseases. In addition, the research community is beginning to compile metrics for patients to quantify and adequately express opinions on disease development, pain management and palliative care.

For Pedro M. Machado, MD, PhD, consultant rheumatologist at the Centre for Rheumatology and MRC Centre for Neuromuscular Diseases at University College London, understanding the basics is of critical importance. In a presentation at the EULAR Congress in June, he called spondyloarthritis “an umbrella term for a group of diseases that share genetic, clinical, immunological and imaging features, such as arthritis, enthesitis, dactylitis, chronic back pain, loss of spinal mobility, uveitis, psoriasis and inflammatory bowel disease.”

Editorial

Spondyloarthritis, HIV and the Lessons of History

Healio Rheumatology, September 2017
Leonard H. Calabrese, DO
The history of the construct of spondyloarthritis as it evolved from ankylosing spondylitis from the late 19th century until now is remarkable to me. Why? Because it…
In the Journals

Anterior uveitis impacted physical QoL, particularly with underlying SpA

September 12, 2017

Chronic inflammatory rheumatic disease common in monoarthritis

September 6, 2017
Among patients with recent-onset arthritis, roughly one-fourth develop chronic inflammatory rheumatic disease after 2 years, according to findings. In the study…
More Headlines »
CME

Timing of Tourniquet Release in Total Knee Arthroplasty: July 2015

The authors conducted a meta-analysis to determine the optimal tourniquet application strategy in total knee…
More »
Video
Meeting News Coverage

VIDEO: Arthritis Power increases physician understanding of patients’ unmet needs

November 10, 2015
More »
Resource Centers
Rheumatology Nurses Society Annual Conference

Rheumatology Nurses Society Annual Conference

CME

Posterior Tibialis Tendon Dysfunction: Overview of Evaluation and Management. June 2015

The posterior tibialis is a muscle in the deep posterior compartment of the calf that plays several key roles in the…
More »
Advertisement
Advertisement